Loading
Proved that letting patients report symptoms electronically during chemotherapy improves quality of life and survival.
Ethan Basch led the randomised trial showing that systematic electronic patient-reported symptom monitoring during chemotherapy improves quality of life, reduces emergency visits and extends overall survival, and the national PRO-TECT trial confirming it in community practices. He developed the PRO-CTCAE toxicity instrument with the NCI and has shaped FDA and ASCO policy on patient-reported outcomes.
Shares the tags supportive-care, outcomes.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/